N01HC95183/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	1
2009	2
2010	6
2011	7
2012	10
2013	8
2014	12
2015	10
2016	10
2017	6
2018	8
2019	4
2020	3
2021	3
2022	2
2023	1
2024	0

1

Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort : Rapid kidney function decline and heart failure in T2D.

Bueno Junior CR, Bano A, Tang Y, Sun X, Abate A, Hall E, Mitri J, Morieri ML, Shah H, Doria A. Bueno Junior CR, et al. Cardiovasc Diabetol. 2023 Jun 26;22(1):131. doi: 10.1186/s12933-023-01869-6. Cardiovasc Diabetol. 2023. PMID: 37365586 Free PMC article.

2

Waist Circumference and Body Mass Index Variability and Incident Diabetic Microvascular Complications: A Post Hoc Analysis of ACCORD Trial.

Hukportie DN, Li FR, Zhou R, Zheng JZ, Wu XX, Wu XB. Hukportie DN, et al. Diabetes Metab J. 2022 Sep;46(5):767-780. doi: 10.4093/dmj.2021.0258. Epub 2022 May 10. Diabetes Metab J. 2022. PMID: 35584801 Free PMC article. Clinical Trial.

3

Visual acuity outcomes after cataract surgery in type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study.

Lee D, Agron E, Keenan T, Lovato J, Ambrosius W, Chew EY; ACCORD Eye Study Research Group. Lee D, et al. Br J Ophthalmol. 2022 Nov;106(11):1496-1502. doi: 10.1136/bjophthalmol-2020-317793. Epub 2021 Jun 18. Br J Ophthalmol. 2022. PMID: 34625432 Free PMC article.

4

Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies.

McDonough CW, Warren HR, Jack JR, Motsinger-Reif AA, Armstrong ND, Bis JC, House JS, Singh S, El Rouby NM, Gong Y, Mychaleckyj JC, Rotroff DM, Benavente OR, Caulfield MJ, Doria A, Pepine CJ, Psaty BM, Glorioso V, Glorioso N, Hiltunen TP, Kontula KK, Arnett DK, Buse JB, Irvin MR, Johnson JA, Munroe PB, Wagner MJ, Cooper-DeHoff RM. McDonough CW, et al. Clin Pharmacol Ther. 2021 Sep;110(3):723-732. doi: 10.1002/cpt.2355. Epub 2021 Aug 15. Clin Pharmacol Ther. 2021. PMID: 34231218 Free PMC article.

5

Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial.

Tang Y, Shah H, Bueno Junior CR, Sun X, Mitri J, Sambataro M, Sambado L, Gerstein HC, Fonseca V, Doria A, Pop-Busui R. Tang Y, et al. Diabetes Care. 2021 Jan;44(1):164-173. doi: 10.2337/dc20-1842. Epub 2020 Nov 3. Diabetes Care. 2021. PMID: 33144354 Free PMC article.

6

Multiple predictively equivalent risk models for handling missing data at time of prediction: With an application in severe hypoglycemia risk prediction for type 2 diabetes.

Ma S, Schreiner PJ, Seaquist ER, Ugurbil M, Zmora R, Chow LS. Ma S, et al. J Biomed Inform. 2020 Mar;103:103379. doi: 10.1016/j.jbi.2020.103379. Epub 2020 Jan 28. J Biomed Inform. 2020. PMID: 32001388 Free PMC article.

7

PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid.

Morieri ML, Shah HS, Sjaarda J, Lenzini PA, Campbell H, Motsinger-Reif AA, Gao H, Lovato L, Prudente S, Pandolfi A, Pezzolesi MG, Sigal RJ, Paré G, Marcovina SM, Rotroff DM, Patorno E, Mercuri L, Trischitta V, Chew EY, Kraft P, Buse JB, Wagner MJ, Cresci S, Gerstein HC, Ginsberg HN, Mychaleckyj JC, Doria A. Morieri ML, et al. Diabetes. 2020 Apr;69(4):771-783. doi: 10.2337/db19-0973. Epub 2020 Jan 23. Diabetes. 2020. PMID: 31974142 Free PMC article. Clinical Trial.

8

A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies.

Tang Y, Lenzini PA, Pop-Busui R, Ray PR, Campbell H, Perkins BA, Callaghan B, Wagner MJ, Motsinger-Reif AA, Buse JB, Price TJ, Mychaleckyj JC, Cresci S, Shah H, Doria A. Tang Y, et al. Diabetes. 2019 Aug;68(8):1649-1662. doi: 10.2337/db19-0109. Epub 2019 May 24. Diabetes. 2019. PMID: 31127053 Free PMC article.

9

Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model.

Copetti M, Shah H, Fontana A, Scarale MG, Menzaghi C, De Cosmo S, Garofolo M, Sorrentino MR, Lamacchia O, Penno G, Doria A, Trischitta V. Copetti M, et al. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4900-4908. doi: 10.1210/jc.2019-00215. J Clin Endocrinol Metab. 2019. PMID: 31087060 Free PMC article.

10

Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes.

Chauhan K, Verghese DA, Rao V, Chan L, Parikh CR, Coca SG, Nadkarni GN. Chauhan K, et al. Kidney Int. 2019 Feb;95(2):439-446. doi: 10.1016/j.kint.2018.09.019. Epub 2018 Dec 24. Kidney Int. 2019. PMID: 30591223 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

76 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year